Cette traduction est en cours de préparation. En attendant, nous affichons temporairement la version originale en anglais.
Entreprise · 21/12/19941 min de lecture
Animal Drugs, Feeds, and Related Products; Albendazole Suspension
Traduction automatique locale · Langue originale de la source
Résumé
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by SmithKline Beecham Animal Health Products. The NADA provides for use of albendazole suspension (Valbazen ) as an anthelmintic in sheep. The regulations are also amended to establish a tolerance for albendazole residue in sheep liver.
Langue originale de la source: Federal Register — Health and Human ServicesOuvrir le communiqué original →